Charles Semba P.'s most recent trade in DiaMedica Therapeutics Inc was a trade of 3,355 Common Stock done at an average price of $8.4 . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc | Charles P. Semba | Director | Grant, award, or other acquisition of securities at price $ 8.42 per share. | 02 Jan 2026 | 3,355 | 47,963 (0%) | 0% | 8.4 | 28,249 | Common Stock |
| DiaMedica Therapeutics Inc | Charles P. Semba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 32,162 | 32,162 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | Charles Semba P. | Director | Grant, award, or other acquisition of securities at price $ 5.34 per share. | 02 Jan 2025 | 5,290 | 44,608 (0%) | 0% | 5.3 | 28,249 | Voting Common Shares, no par value per share |